BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 749944)

  • 1. Exploratory analysis of disease prevalence data from survival/sacrifice experiments.
    Turnbull BW; Mitchell TJ
    Biometrics; 1978 Dec; 34(4):555-70. PubMed ID: 749944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Log-linear models in the analysis of disease prevalence data from survival/sacrifice experiments.
    Mitchell TJ; Turnbull BW
    Biometrics; 1979 Mar; 35(1):221-34. PubMed ID: 315241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiparametric analysis of tumor incidence rates in survival/sacrifice experiments.
    Portier CJ; Dinse GE
    Biometrics; 1987 Mar; 43(1):107-14. PubMed ID: 3567301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing a model of aging in animal experiments.
    Tyurin YuN ; Yakovlev AYu ; Shi J; Bass L
    Biometrics; 1995 Mar; 51(1):363-72. PubMed ID: 7766791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer risk in mice: analysis of fractionation effects and neutron RBE with a biologically motivated model.
    Heidenreich WF; Carnes BA; Paretzke HG
    Radiat Res; 2006 Nov; 166(5):794-801. PubMed ID: 17067205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonparametric joint estimators for disease resistance and survival functions in survival/sacrifice experiments.
    Kodell RL; Shaw GW; Johnson AM
    Biometrics; 1982 Mar; 38(1):43-58. PubMed ID: 7082762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiencies of experimental designs for an illness-death model.
    Borgan O; Liestøl K; Ebbesen P
    Biometrics; 1984 Sep; 40(3):627-38. PubMed ID: 6518242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonparametric estimation of the distribution of time to onset for specific diseases in survival/sacrifice experiments.
    Turnbull BW; Mitchell TJ
    Biometrics; 1984 Mar; 40(1):41-50. PubMed ID: 6733233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
    Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
    Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating constraints that allow survival-adjusted incidence analyses in single-sacrifice studies.
    Dinse GE
    Biometrics; 1993 Jun; 49(2):399-407. PubMed ID: 8369376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of survival and cause of death statistics for mice under single and duration-of-life gamma irradiation.
    Grahn D; Fry RJ; Lea RA
    Life Sci Space Res; 1972; 10():175-86. PubMed ID: 11898837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of time and age patterns in cancer risk for A-bomb survivors.
    Pierce DA; Vaeth M; Preston DL
    Radiat Res; 1991 May; 126(2):171-86. PubMed ID: 2023988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating morbidity risks with variable age of onset: review of methods and a maximum likelihood approach.
    Risch N
    Biometrics; 1983 Dec; 39(4):929-39. PubMed ID: 6671128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misclassification in case-control studies with two dichotomous risk factors.
    Tzonou A; Kaldor J; Smith PG; Day NE; Trichopoulos D
    Rev Epidemiol Sante Publique; 1986; 34(1):10-7. PubMed ID: 3726220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.